At Geneventivwe Re Blazing A Trail We Re Driven By Curiosity We Re Fueled By Learning Expressed As Innovation Our Mission Is To Discoverdevelop And Deliver Gene Therapies For Patients Who Had No Hope Of A Cure Aeuntil Now We Are Founded On Discovery Bringing Together Insights Into Adeno Associated Virusaavdirected Gene Therapyhemophilia And How To Use The Common Pathway In The Clotting Cascade To Surmount The Obstacle Of Inhibitors Patients With Inhibitors Are Unable To Respond To Current Therapies And Gene Therapies In Development Due To Neutralizing Antibodiesinhibitorsformed By The Body In Response To Treatment With Missing Clotting Factor Our Goal Is To Cure Inhibitor Patients With A Single Lifetime Infusionnot To Offer A Half Measure Of Weekly Injections Of A Bypass Agent Geneventiv Therapeutics Is Investigational New Drugindenablinggene Therapy Company Developing The First Effective Gene Therapy For Hemophilia A And Hemophilia B With Or Without Inhibitors Join Us As We Carve A Path To A Cure For All Types Of Hemophilia Delivered In A Singlelife Changing Infusion To Learn More About Geneventivvisit Www Geneventiv Com
